How-To Guide
How do regulated brands approve social posts in healthcare and finance?
How healthcare and finance brands route a social post through content and type tests, name the approvers, and keep a record that satisfies FINRA and FDA.
Regulated brands approve social posts with two content tests and one record, not with a platform setting. The first test is what the post contains: protected health information or a product promotion on the health side, a communication about investments on the finance side. The second is what kind of communication it is: a static post that stands on the page, or an interactive exchange with a customer. FINRA says most static material needs a registered principal's approval before use, while interactive material can publish without prior approval if it is supervised like correspondence. HIPAA requires written authorization before protected health information is used for marketing, and the FTC requires clear disclosure of paid endorsements. The record names the approver, the version and the dates, so the decision can be reconstructed later.
- Finance approval follows content type: static posts need a principal before use, while supervised interactive replies can move through a documented review queue.
- Healthcare approval follows the information and the promotion: PHI and marketing both need written authorization, and drug or device claims need the evidence and risk information that support them.
- The record is what survives an audit: the version, the approver's name, the approval date and the first and last use dates.
The short answer
Regulated brands approve social posts with two tests and one record. Neither test is a platform setting, and neither can be delegated to a scheduling tool. The first test looks at what the post contains: protected health information, a product claim, an endorsement, or a communication about investments. The second test looks at what kind of communication it is: a static post that stands on the page, or an interactive exchange with a customer. Finance regulators split approval along that second line. Health regulators split it along the first. The record then captures who approved the exact version, when, and which dates the post ran.
FINRA is the clearest published example because it names both paths. Most static material must be approved by a registered principal before use, while interactive material does not require principal approval prior to use if it is supervised in a manner similar to the way firms supervise correspondence (FINRA, social media). Rule 2210 adds the record: an appropriately qualified registered principal must approve each retail communication before its use or filing, and the file must name that principal and the date of approval (FINRA Rule 2210).
Healthcare runs on a different gate. HIPAA requires a patient's written authorization before protected health information is used for marketing, apart from limited exceptions (HHS, marketing). The FDA adds promotional review for drugs and devices, and the FTC adds disclosure and substantiation duties for endorsements (FTC Endorsement Guides). A brand that sells in both sectors therefore runs two approval paths at once, and the record has to satisfy whichever path the post took.
The two tests that route a regulated social post to an approver, drawn from FINRA's static and interactive split, HHS marketing guidance and the FTC Endorsement Guides, all read 18 November 2026. The routing is the brand's policy, not a platform rule.
Make it work for your brand
Find it. Remake it. Post it. Superdirector turns the viral formats in your niche into your brand's carousels, X posts and video scripts, and keeps the calendar full.
Two tests decide the approval path
Start with the content and the communication type, not with the calendar or the campaign. The table routes a post to the right approver before anyone writes a caption.
| Question | If yes | Source |
|---|---|---|
| Does the post contain protected health information? | Do not publish it without written authorization, or remove the identifiable detail. | HHS marketing guidance |
| Does the post promote a product or service to patients? | Treat it as marketing under HIPAA and check whether authorization is needed. | HHS marketing guidance |
| Is it a communication about investments to retail investors? | A registered principal approves it before use or filing. | FINRA Rule 2210 |
| Is it a static post or a live exchange? | Static material usually needs prior principal approval; interactive material needs supervision. | FINRA social media page |
| Is an influencer paid or given something of value? | The disclosure must be clear and conspicuous, and the brand must train and monitor the influencer. | FTC Endorsement Guides |
In theory the two tests separate cleanly. In a real calendar they blur. A single campaign can contain a static image that needs a principal, a set of replies that need supervision, and an influencer cut that needs an FTC disclosure. Route each asset on its own. Treating the whole campaign as one approval is the first place a regulated brand loses the trail.
The finance split: static posts need a principal
FINRA does not apply one approval rule to every social post. It separates static content from interactive communication, then assigns a different control to each. Static content is typically posted for the longer term and lacks the immediacy of a real-time conversation. Interactive communication is typically real-time and involves a dialog with third parties. The topic page states the consequence plainly: most static material must be approved by a registered principal prior to use (FINRA, social media).
Notice 10-06 gives the same split its blog-era form. FINRA considers static postings to constitute "advertisements" under Rule 2210, and a firm that sponsors such a blog must obtain prior principal approval of any posting. A blog used for real-time interactive communications does not require prior principal approval, but those communications must be supervised (FINRA Notice 10-06).
The supervised path is not a lighter version of the same review. It is a different control with its own paperwork. If a firm lets associated persons use interactive communications before principal approval, its written supervisory procedures must provide for training on the content standards, surveillance that tests for compliance, the actions taken when problems are detected, and documentation of findings and corrective actions. A brand that chooses this path has to show the procedure, not just the intention.
Recordkeeping is the part that survives staff changes. Firms must retain records of communications related to their business as such, and the FINRA page puts the period at not less than three years. Rule 2210 then lists what a retail communication record must contain, including the name of the approving principal and the approval date (FINRA Rule 2210).
Third-party posts need their own line on the approval list. They generally fall outside FINRA's advertising rules unless the firm adopts or becomes entangled with the content, and adoption happens when a firm endorses or approves third-party content. A repost with an endorsement can turn someone else's words into the firm's communication.
The healthcare gates: authorization before promotion
The HIPAA gate is about information, not tone. HHS defines marketing as a communication about a product or service that encourages recipients to purchase or use the product or service. When a communication is marketing, it can occur only if the covered entity first obtains the individual's authorization (HHS, marketing). A patient story, a before-and-after photo or a testimonial can cross that line when it carries identifiable health information and promotes a service.
One part of the definition has no exceptions. When a covered entity discloses protected health information to another entity in exchange for payment so that the other entity can promote its own product, the individual must authorize the communication first. Covered entities also may not sell lists of patients or enrollees without obtaining authorization from each person on the list. A social team that buys an audience list, or hands one to a partner, has left the ordinary approval workflow.
Tracking is the newer healthcare gate. HHS and the FTC jointly wrote to hospital systems and telehealth providers about privacy and security risks from online tracking technologies (HHS guidance index). A campaign that drops a pixel on a patient-facing page is a privacy decision before it is a social decision, and the approval should include whoever owns that page.
FDA and FTC review sit beside the HIPAA gate. The FDA has draft guidance on presenting risk and benefit information on social platforms with character space limitations, and on correcting independent third-party misinformation about prescription drugs and devices (FDA, using social media). The FTC requires endorsements to be honest and not misleading, and it says a brand needs reasonable programs to train and monitor the influencers it pays and directs (FTC Endorsement Guides). Hootsuite's healthcare guide turns that into a role: a clinician or compliance officer reviews anything that touches health claims or patient-facing messaging (Hootsuite).
What belongs on the pre-approval list
A pre-approval list is a content rule, not a person's inbox. Put a post on the list when any one of these is true, and name the approver for that type in advance.
- The post names a product, service, price or promotion, which can make it marketing under HIPAA or a retail communication under FINRA.
- The post shows or implies a patient, a patient's family or an identifiable health detail.
- The post makes a health, efficacy or safety claim that a reviewer has to check against evidence.
- The post recommends a specific investment product or promotes a specific securities offering.
- The post is paid or incentivised, including an influencer post and an employee advocacy post shared for value.
- The post is static brand content on an account the firm operates, which is the default prior-approval case in finance.
Two categories can move without prior approval when the conditions hold. Supervised replies can publish inside a documented monitoring queue, because FINRA's interactive path allows it. Template posts can publish when the exact template is already approved and the person using it stays inside the approved wording. Notice 10-06 describes firms that maintain databases of previously approved communications and give personnel routine access to those templates. The template is the approval; a rewrite is a new communication.
The pre-approval list and its two documented exceptions, built from FINRA's interactive supervision path, its pre-approved template practice and HHS marketing authorization, read 18 November 2026.
Who may publish without a second check
Approval authority and publishing authority are different permissions. A clinical reviewer can approve the health claim and still have no business clicking publish. A social manager can operate the account and still have no authority to clear a product claim. The table keeps the two apart.
| Role | May publish alone | Condition |
|---|---|---|
| Social manager using an approved template | Yes, for that template only | The wording and asset match the approved version exactly. |
| Registered principal in finance | Yes, as the approver | The communication is within the principal's qualification and the record is made. |
| Clinical reviewer in healthcare | No | They approve the claim, not the account operation. |
| Compliance officer in healthcare | Only when the policy says so | The role has both content authority and account access, and the sign-off is recorded. |
| Agency or freelancer operating the account | No | They can schedule an approved asset, but they cannot supply the regulated approval. |
Sprinklr describes the operational version of this split: static content must undergo pre-approval, while interactive content is subject to post-review (Sprinklr). The split is only safe when the account permission matches the approval type. If the person who schedules a static post cannot tell whether it was approved, the workflow has already failed.
What the approval record has to name
The record is the part a regulator can read months later. For a finance communication, Rule 2210 states the core fields: a copy of the communication, the dates of first and last use, and the name of the registered principal who approved it with the date of approval. Where a communication was not approved before first use, the record also names the person who prepared or distributed it (FINRA Rule 2210).
- The exact version that was approved, with its caption, image bytes and account.
- A copy of the communication and the dates of first and last use.
- The name of the registered principal who approved it and the date of approval.
- The name of the person who prepared or distributed any communication that published before approval.
- The written patient authorization when the post carries protected health information for marketing.
- The evidence and risk information relied on for any drug, device or health claim.
- The disclosure text and placement for any paid or incentivised endorsement.
Hootsuite's healthcare guide adds the operational fields a brand usually wants beside the regulator's: which posts were AI-assisted and who signed off (Hootsuite). Those fields do not replace the regulator's list. They make the same approval readable to the team that runs the account next month.
The fields an approval record has to carry, organised from FINRA Rule 2210 recordkeeping and HHS marketing authorization, read 18 November 2026. The evidence band is the brand's own addition.
Where approvals break in practice
Approvals fail in ordinary ways a policy document rarely catches. Five are common in regulated social teams.
- The approval lives in an email or a chat, and the version that publishes is a later edit. The record has a yes, but not for the bytes that ran.
- A static post is edited after sign-off. Changing a price, a claim or a disclaimer turns an approved communication into an unapproved one.
- A reply is treated as a static post, or a static post is treated as a reply. The two paths carry different approval and supervision duties.
- A third-party post is reposted with an endorsement. The brand has adopted content it did not approve, and the record shows nothing.
- A platform label or disclosure is treated as the authorization. A label says AI was used or that a post is paid, not that the patient consented or the claim is true.
A checklist to run on every post
Run the questions in this order, because an earlier yes changes the approver for everything after it.
- Does the post contain protected health information? If yes, stop until written authorization is on file or the detail is removed.
- Does it promote a product or service to patients? If yes, run the HIPAA marketing test before the social review.
- Does it make a health, efficacy or safety claim? If yes, attach the evidence and the risk information the reviewer will check.
- Does it recommend a specific investment product or promote an offering? If yes, route it to a registered principal before use or filing.
- Is it static or interactive? Static brand content takes prior approval; a supervised reply takes the documented monitoring path.
- Who is named as the approver, and does that person hold the authority the post needs? The record must answer this before scheduling.
- Does the post link to or repost third-party content? Check whether the brand would adopt or become entangled with it.
This checklist is deliberately short. A longer one gets skipped on a busy week, and a skipped question is how a regulated account publishes without the yes it needed.
Where Superdirector fits
Superdirector operates social accounts, and its plans do not move a regulated brand's approval decision. The $199 plan runs one AI-operated social account under account-level standing posting permission, which means the account can publish on that standing permission while the brand's own policy decides what enters the queue and who clears it. The $29 plan covers MCP access and hands-on creation only. Neither plan replaces a registered principal, a clinical reviewer or a compliance officer.
That boundary is the useful part for a regulated team. Keep the two tests, the approver names and the record fields in the brand's own policy, and let the operated account publish what the policy has already cleared. The approval stays with the role the regulator names, and the account keeps a working queue instead of a second approval layer.